378 A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2 antagonist, in patients with solid malignancies
de Weger, V, Lolkema, M.P, Dickson, M, Le Cesne, A, Wagner, A, Merqui-Roelvink, M, Varga, A, Tap, W, Schwartz, G, Demetri, G, Zheng, W, Tuffal, G, Mace, S, Miao, H, Schellens, J.H.M, de Jonge, M
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article